The JetBlue, Ford and SoftBank-backed weather data provider hiked its overall funding to over $185m as it rebranded from ClimaCell.

MD Anderson Cancer Center spinout OncoResponse has added $40.6m to its coffers thanks to series C investors including Arch Venture Partners.

Existing backers Lilly Asia Ventures and Osage University Partners helped the UCSF cancer therapy spinout close its series A round.

Existing backers Lilly Asia Ventures and Osage University Partners helped the UCSF cancer therapy spinout close its series A round.

Lilly Asia Ventures has returned to co-lead the cancer immunotherapy developer’s series C round with Greater Bay Area Homeland Investments.

Access Biotechnology is among the initial investors disclosed by Eliem Therapeutics, which is targeting neuronal excitability disorders.

SoftBank Ventures Asia and Bangkok Bank were among the investors that added $65m to the online share trading platform's series A round.

GV led the first disclosed round for the anti-viral nasal spray developer, investing $47.2m together with F-Prime Capital, Casdin Capital and Brook Byers.

Sumitomo and Asahi contributed to a series A round that will support the expansion of the video storytelling platform developer in India.

Propel Venture Partners returned to help the employee benefits platform developer hike its total funding to more than $70m.